Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Other Operating Expenses: 2019-2024

Historic Other Operating Expenses for Biodesix (BDSX) over the last 6 years, with Dec 2024 value amounting to $15.8 million.

  • Biodesix's Other Operating Expenses fell 1.58% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.4 million, marking a year-over-year increase of 11.02%. This contributed to the annual value of $15.8 million for FY2024, which is 21.12% up from last year.
  • Latest data reveals that Biodesix reported Other Operating Expenses of $15.8 million as of FY2024, which was up 21.12% from $13.1 million recorded in FY2023.
  • Biodesix's Other Operating Expenses' 5-year high stood at $32.1 million during FY2021, with a 5-year trough of $13.1 million in FY2023.
  • In the last 3 years, Biodesix's Other Operating Expenses had a median value of $14.2 million in 2022 and averaged $14.4 million.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first soared by 123.95% in 2020, then crashed by 55.71% in 2022.
  • Yearly analysis of 5 years shows Biodesix's Other Operating Expenses stood at $22.8 million in 2020, then soared by 40.87% to $32.1 million in 2021, then tumbled by 55.71% to $14.2 million in 2022, then decreased by 8.30% to $13.1 million in 2023, then grew by 21.12% to $15.8 million in 2024.